PTE - パタ―ソンUTIエナジ― （PolarityTE Inc.） パタ―ソンUTIエナジ―PTEのチャート
PTEの企業情報
| symbol | PTE |
|---|---|
| 会社名 | Patterson-UTI Energy Inc. （パタ―ソンUTIエナジ―） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Biological Products (No Diagnostic Substances) |
| 業種 | バイオテクノロジ―_メディカルリサ―チ エネルギ―（Energy） |
| 概要 | 事業概要 ポラリティTE(PolarityTE Inc)（旧名:Majesco Entertainment Company）はオンライン･プラットフォームによってソフトウェアを開発･販売･発行した技術会社である。同社はコンピューター、携帯用デバイス及びゲーム機上のゲーム向けのアプリケーションを開発する。同社は再生医療と再生医学関連の特許出願･技術情報、並びに再生医療関連診断･治療に使用されるソフトウェア･アプリケーションの所有者である。同社は皮膚、骨、肌、軟骨、脂肪、血管及び神経の再生用患者自身の組織基質を使用する技術の規制当局の承認の取得を求める。ポラリティTEプラットフォームは再生の簡易化及び細胞の機能正常化を促進する。同プラットフォームは全部の細胞、組織、複合組織に応用されて、細胞･組織極性を誘発する他、人体の自然作用を反映する機能性組織を創造する。 パタ―ソンUTIエナジ―は、米国の掘削事業請負会社。大手、独立系石油・ガス会社から石油と天然ガスの掘削を請け負い、北米にて掘削リグを所有、操業する。またテキサス州とアパラチア盆地で坑井仕上げ、坑井刺激、セメンチングなどを行うほか、テキサス州とニュ―メキシコ州にある石油・ガス田の探鉱、開発、作業権を所有する。 PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates a dynamic and self-propagating product designed to regenerate the target tissues. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing. |
| 本社所在地 | 10713 W. Sam Houston Pkwy. N. Suite 800 Houston TX 77064 USA |
| 代表者氏名 | Denver Lough デンバーラフ |
| 代表者役職名 | Chairman of the Board Chief Executive Officer Chief Scientific Officer |
| 電話番号 | +1 385-237-2279 |
| 設立年月日 | 28491 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 8000人 |
| url | www.patenergy.com |
| nasdaq_url | https://www.nasdaq.com/symbol/pte |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -54.98500 |
| 終値（lastsale） | 16.1 |
| 時価総額（marketcap） | 345753457 |
| 時価総額 | 時価総額（百万ドル） 274.67000 |
| 売上高 | 売上高（百万ドル） 0.43200 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 191.08100 |
| 当期純利益 | 当期純利益（百万ドル） -61.77400 |
| 決算概要 | 決算概要 BRIEF: For the nine months ended 31 July 2018 Polarityte Inc revenues increased from $0K to $432K. Net loss applicable to common stockholders excluding extraordinary items decreased 57% to $51.7M. Revenues reflect Regenerative Medicine segment increase from $0K to $244K. Lower net loss reflects Research and development - intellectual decrease from $104.7M (expense) to $0K. |
PTEのテクニカル分析
PTEのニュース
PolarityTE PT Lowered to $1 at Northland Capital Markets 2022/12/28 14:04:01 Investing.com
https://www.investing.com/news/pro/polarityte-pt-lowered-to-1-at-northland-capital-markets-432SI-2970719
PolarityTE stock jumps 10% on LOI for $7.5M buyout by shareholder Brauser 2022/12/27 14:57:00 Seeking Alpha
PolarityTE (PTE) stock jumped 10.4% on Tuesday after the firm announced a non-binding letter of intent with shareholder Michael Brauser for his bid to acquire the firm for $1.03/share…
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company 2022/12/27 13:30:00 PR Newswire
SALT LAKE CITY, Dec. 27, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the "Company"), today announced that it signed a non-binding letter of intent (the "LOI") with Michael Brauser ("Brauser") for…
PolarityTE, Inc.: PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company 2022/12/27 13:30:00 Finanz Nachrichten
SALT LAKE CITY, Dec. 27, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the "Company"), today announced that…
PolarityTE GAAP EPS of -$0.47 2022/11/10 22:20:40 Seeking Alpha
PolarityTE press release (PTE): Q3 GAAP EPS of -$0.47.The Company had cash and cash equivalents of $16.1 million and working capital of $15.7 million at September 30, 2022.
PolarityTE PT Lowered to $1 at Northland Capital Markets 2022/12/28 14:04:01 Investing.com
https://www.investing.com/news/pro/polarityte-pt-lowered-to-1-at-northland-capital-markets-432SI-2970719
PolarityTE stock jumps 10% on LOI for $7.5M buyout by shareholder Brauser 2022/12/27 14:57:00 Seeking Alpha
PolarityTE (PTE) stock jumped 10.4% on Tuesday after the firm announced a non-binding letter of intent with shareholder Michael Brauser for his bid to acquire the firm for $1.03/share…
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company 2022/12/27 13:30:00 PR Newswire
SALT LAKE CITY, Dec. 27, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the "Company"), today announced that it signed a non-binding letter of intent (the "LOI") with Michael Brauser ("Brauser") for…
PolarityTE, Inc.: PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company 2022/12/27 13:30:00 Finanz Nachrichten
SALT LAKE CITY, Dec. 27, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the "Company"), today announced that…
PolarityTE GAAP EPS of -$0.47 2022/11/10 22:20:40 Seeking Alpha
PolarityTE press release (PTE): Q3 GAAP EPS of -$0.47.The Company had cash and cash equivalents of $16.1 million and working capital of $15.7 million at September 30, 2022.
PolarityTE GAAP EPS of -$0.47 2022/11/10 22:20:40 Seeking Alpha
PolarityTE press release (PTE): Q3 GAAP EPS of -$0.47.The Company had cash and cash equivalents of $16.1 million and working capital of $15.7 million at September 30, 2022.
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update 2022/11/10 21:30:00 PR Newswire
SALT LAKE CITY, Nov. 10, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the quarterly period ended September 30, 2022. Recent Business…
PolarityTE Shares Jump After Non-Binding Buyout Offer Of $1.25/Share 2022/11/09 16:08:21 Benzinga
PolarityTE Inc (NASDAQ: PTE ) shares are surging after it received an unsolicited, non-binding offer (followed by an amended offer) from Michael Brauser to acquire all of the outstanding common stock of the company not owned by him for $1.25 per share in cash . The company''s board and a special committee will carefully review the terms and conditions of the … Full story available on Benzinga.com
Biotech firm Polarityte surges as it confirms receipt of $1.25/share acquisition bid 2022/11/09 13:17:00 Seeking Alpha
Polarityte (PTE) shares surged 51% Wednesday morning after the biotechnology company confirmed receipt of an unsolicited, non-binding offer from Michael Brauser to acquire all of…
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company 2022/11/09 13:00:00 PR Newswire
SALT LAKE CITY, Nov. 9, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November…